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The CCR4-NOT complex is a deadenylation complex, which plays a major role for mRNA stability. The
complex is conserved from yeast to human and consists of nine proteins NOT1–NOT5, CCR4, CAF1,
CAF40 and CAF130. We have successfully isolated the complex using a Protein A tag on NOT1, fol-
lowed by cross-linking on a glycerol gradient. All components of the complex were identiﬁed by
mass spectrometry. Electron microscopy of negatively stained particles followed by image recon-
struction revealed an L-shaped complex with two arms of similar length. The arms form an acces-
sible cavity, which we think could provide an extensive interface for RNA-deadenylation.
Structured summary of protein interactions:
CAF1 physically interacts with CCR4 and NOT1 by tandem afﬁnity puriﬁcation (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction enylases are incorporated in the same complex. Furthermore,Gene expression in eukaryotic cells progresses through differ-
ent steps, which are tightly regulated to ensure the integrity of
the transcriptome. After transcription the 30-end of the mRNA is
adenylated with a poly-A-tail, which is important for transport to
the cytoplasm and essential for offsetting mRNA-degradation. Ade-
nylation is counterbalanced by deadenylation, which removes the
poly-A-tail and thus enables the degradation of the mRNA in the
cytoplasm. Poly (A) deadenylation is catalyzed by the CCR4-NOT
complex, which is conserved from yeast to human [1–3]. In yeast
the complex occurs in two different sizes with approximate masses
of 1.0 MDa and 1.9 MDa [4–6]. The complex consists of at least
nine core subunits, namely CCR4, CAF1, CAF40, CAF130 and
NOT1–5 [2,4,5,7,8]. Of these proteins only NOT1 is essential for via-
bility [9]. Except for CAF40 and CAF130 all other proteins were ini-
tially identiﬁed by genetic selection for transcriptionally regulating
elements [10], which suggests that the complex plays a global reg-
ulatory role in gene expression.
The CCR4-NOT-complex contains CCR4 and CAF1, which are the
major mRNA deadenylases in yeast [11,12]. Both proteins exert a
30–50 exonulclease activity for mRNA, with a preference for poly
A [11,13]. Despite structures of both proteins from different spe-
cies are known [14–17] it remains unclear why two different dead-al Societies. Published by Elsevier
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8650 (B. Böttcher).
ertorabi), bettina.boettcher@structural insights into the organization of the whole complex
are still missing. Here we show an effective method for purifying
a homogeneous complex, which we have studied by electron
microscopy and image reconstruction. These investigations give a
ﬁrst glimpse of the three-dimensional structure of the CCR4-
NOT-complex from yeast.2. Materials and methods
Yeast strain MATa ade2 arg4 leu2-3, 112 trp1-289 ura3-5 (A kind
gift from Anne-Claude Gavin, EMBL-Heidelberg) with a TAP-tag
[18] fused either to the N-terminus of CAF1 or NOT1 was used.
2.1. Cell growth
A single colony of a freshly stroke plate was used to inoculate
20 ml YPD media (2% yeast extract, 1% peptone, 2% glucose) with
additional 3% glucose for overnight growth at 30 C. 750 ml of
YPD media were inoculated with the overnight cell culture and
let it grow overnight until OD = 7–9. Cells were harvested and cen-
trifuged for 15 min at 5000g. Typically, 12 g cell pellet/L of cell
culture was obtained. The pellet was washed with distilled water,
ﬂash frozen in liquid nitrogen and stored at 80 C.
2.2. Puriﬁcation and preparation for electron microscopy analysis
All the steps have been carried out in 4 C unless indicated:
150 g of cells were thawed in 240 ml of lysis buffer (200 mM TrisB.V. Open access under CC BY license.
Fig. 1. Biochemical characterization of the puriﬁcation of the CCR4-NOT complex. (A) Coomassie stained SDS-gels of tandem afﬁnity puriﬁcation with CAF1 as bait after TEV
cleavage (left) and after calmodulin puriﬁcation (right). (B) Coomassie stained SDS-gels of tandem afﬁnity puriﬁcation with NOT1 as bait after TEV cleavage (left) and after
TEV-cleavage followed by a glycerol gradient (right). (C) Blue Native gel (3–12%) of the non-cross-linked CCR4-NOT complex recovered from the glycerol gradient (left) and
molecular weight markers (right). The complex forms two species (arrows). (D) Dot blot assay of fractions of the glycerol gradient using an anti-TAP antibody to identify
NOT1. Fractions in A–C refer to the non-cross-linked complex and in A0–C0 to the cross-linked complex. Fraction 1 is at the bottom of the gradient and has the highest glycerol
and glutaraldehyde (cross-linked complex only) concentration.
F. Nasertorabi et al. / FEBS Letters 585 (2011) 2182–2186 2183HCl pH 7.7, 600 mM Potassium acetate, 10% glycerol, 2 mM Ben-
zamidine, 2 lM Leupeptin, 2 lM Pepstatin A, 4 lM Chymostatin,
3 lM Aprotinin, 1.5 lM Antipain, 1 mM Pefablock SC, and two tab-
lets of complete protease inhibitor cocktail EDTA free (Roche)).
Cells were disrupted with glass beads in lysis buffer using a Pulver-
isette (Fritsch, 3 cycles milling with power set to 350 for 4 min,
1 min break between cycles) and the lysate was diluted with lysis
buffer containing 40% glycerol to have a ﬁnal concentration of 20%
glycerol. The cell lysate was centrifuged at 35 000g for 45 min.
The supernatant was centrifuged at 170 000g for 1.5 h prior to
incubation with 100 ll of IgG sepharose 6 fast ﬂow (GE Healthcare,
USA), which had been pre-equilibrated with the lysis buffer with-
out protease inhibitors, for 2 h on a turning wheel. Afterwards, the
beads were transferred into a MoBiTech column (Mobicol, 35 lm
ﬁlter) and washed with 25 ml of lysis buffer, 25 ml of wash buffer
1 (200 mM Tris HCl pH 7.7, 600 mM Potassium acetate, 0.5 mM
DTT,10% glycerol), 25 ml of wash buffer 2 (200 mM Tris HCl pH
7.7, 600 mM Potassium acetate, 0.5 mM DTT, 10% glycerol, 0.01 %
NP-40), 25 ml of wash buffer 3 (200 mM Tris HCl pH 7.7,
600 mM Potassium acetate, 0.5 mMDTT) and 10 ml of TEV cleaving
buffer (50 mMHEPES pH 7.7, 150 mMNaCl, 0.5 mM DTT). Then the
sample was incubated with 35 lg of TEV protease for 2 h at 16 C
on a turning wheel. The cleaved sample was eluted by adding500 ll of TEV cleaving buffer and was followed by a calmodulin
binding step [18]. Alternatively, the TEV-cleaved, eluted sample
was cross-linked by glutaraldehyde (Electron Microscopy Sciences)
on a glycerol gradient (Graﬁx protocol; [19]). The gradient fractions
were tested by dot blot using an anti TAP antibody (CAB 1001,
Open biosystem, USA), to identify the tagged protein. The fraction
showing the strongest signal in dot-blot was prepared by sandwich
negative staining using 2% uranyl acetate [20]. For evaluating the
effect of cross-linking, the TEV-eluted sample was also puriﬁed
on a glycerol gradient without added glutaraldehyde; followed
by dot-blot and electron microscopy as described above.
2.3. Blue native gel electrophoresis
The most concentrated fraction of the glycerol gradient without
added glutaraldehyde (non-cross-linked sample) was loaded onto
a Native PAGE Novex 3–12% Bis–tris gel (1.0 mm, Invitrogen) fol-
lowed by electrophoresis according to manufacturers’ instructions.
2.4. Electron microscopy
Micrographs were recorded under low dose conditions at a
nominal magniﬁcation of 27 500 with an accelerating voltage of
Fig. 2. Electron microscopic analysis of the CCR4-NOT complex. (A) Micrographs of negatively stained CCR4-NOT-complex without cross-linking (left) and with cross-linking
(right). (B) Two-dimensional averages of the CCR4-NOT complex (top row) with matching projections of the three-dimensional map (central row) and surface presentations
of the map in the same orientation as the projections (bottom row). (C) Fourier–Shell Correlation between two maps calculated from different subsets of particle images.
Fig. 3. Surface representation of the three-dimensional map. The tentative positions of the subunits are indicated. The positions are mainly based on size considerations and
require further experimental validation.
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CCD-camera (TVIPS GmbH). The pixel size was 5.16 Å. For random
conical tilt reconstruction (RCT, [21]) pairs of micrographs were re-
corded, with the sample tilted to –55 (ﬁrst micrograph) and 0
(second micrograph). 156 pairs of micrographs were used for fur-
ther analysis.
2.5. Image processing
7030 pairs of particles from tilted and untilted samples were
selected using Spider WEB [22]. Tilted particles were centered by
translational alignment to mass centered class averages using IMA-GIC [23]. Untilted particles were rotationally and translationally
aligned and classiﬁed. Alignment and classiﬁcation were repeated
several times, using the current best class averages as references.
We calculated a RCT for each class using Spider [22]. Several of
these RCTs were used as reference to start maximum likelihood
3D-sorting [24] of 1000 class averages of untilted particle images
into ﬁve volumes. The process converged to similar volumes irre-
spective of the selected starting volume. Finally, one of the vol-
umes, which represented most of the class averages, was used
for iterative reﬁnement of the spatial orientations of the tilted
and untilted particles by projection matching against projections
of the current best map using Spider. Three-dimensional maps
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space.
A Fourier–Shell correlation (FSC) between two maps that were
calculated from different subsets of particle images, was deter-
mined. The resolution was estimated using the spatial frequency
were the FSC dropped to 0.5 or 0.14, respectively.
Maps were displayed with Chimera [25] and segmented with
the Segger-option for estimating volumes of the sub-domains.3. Results and discussion
The CCR4-NOT complex was puriﬁed according to a modiﬁed
TAP-protocol using both afﬁnity tags of the TAP-tag on the N-ter-
minus of CAF1. This yielded a complex that consisted of three com-
ponents, which we identiﬁed by mass spectrometry as NOT1, CAF1
and CCR4 (Fig. 1A, right panel). However, several other subunits,
which were previously identiﬁed as being part of the CCR4-NOT-
complex (NOT2–5, CAF130, CAF40) were only present after the
TEV cleavage (Fig. 1A, left panel), but were absent after the calmod-
uline puriﬁcation (Fig. 1A, right panel). Especially, most of the sub-
units of the NOT-subcomplex were lost and the band of the NOT1
protein was relatively weak, indicating a recovery of NOT1 in sub-
stoichiometric amounts. Therefore, we changed the bait to the
NOT1-protein, which is the scaffolding protein for the NOT-sub-
complex. Similar to the tag on CAF1, the puriﬁcation yielded a
complex where most of the proteins were present after the TEV
cleavage (Fig.1B, left panel) but with an increased amount of recov-
ered complex (not shown). Next, we considered that binding of this
complex to the Calmodulin beads followed by chelating of Calcium
ions with EGTA might interfere with the complex integrity. There-
fore, we replaced the calmodulin puriﬁcation with a glycerol gradi-
ent that is much milder. This yielded a larger complex, which
contained all the expected nine components of the CCR4-NOT-
complex, namely NOT1–5, CCR4, CAF1, CAF40 and CAF130
(Fig. 1B, right panel).
Electron microscopy of negatively stained samples showed a
large complex with some heterogeneity in size (Fig. 2A, left panel).
This heterogeneity was conﬁrmed by native gels, which showed
two major bands of 1.0 MDa and 0.7 MDa (Fig. 1C, arrows). The fact
that the two species detected in the native gel, originated from the
same fraction of the glycerol gradient, suggested an inherent insta-
bility of the complex. In order to stabilize the complex for further
structural studies, the sample was cross-linked with glutaralde-
hyde (GraFix protocol; [19]). The fractions containing NOT1 were
identiﬁed with a dot-blot-assay against the TAP-tag at NOT1
(Fig. 1D). The blot showed that the NOT1-containing cross-linked
complex had shifted towards higher glycerol concentrations, indi-
cating the recovery of a somewhat larger complex. Electron
microscopy of negatively stained samples conﬁrmed that the
cross-linked CCR4-NOT-complex was more homogeneous than
the non-cross-linked complex. Furthermore, it was virtually free
of random aggregates implying that the shift was not due to ran-
dom-aggregation.
After cross-linking, the homogeneity was sufﬁcient for further
structural analysis by electron microscopy and image processing.
By using RCT [21,22] maximum likelihood sorting [24] and projec-
tion matching [22], we could determine a three-dimensional map
of a typical conformation of the 9-subunit complex. Projections
of this map matched with 2D-averages calculated from particles
that were assigned with the same Euler angles (Fig. 2B) highlight-
ing the validity of the map. The resolution was 33 Å at FSC = 0.5 or
31 Å at FSC = 0.14 (Fig. 2C). The map revealed a ﬂat, L-shaped par-
ticle (Fig. 3) with two arms of similar length (180 Å and 190 Å). The
shorter arm accounted for ca. 600 kDa, whereas the longer, thinner
arm accounted for ca. 300 kDa and the hinge domain forapproximately 100 KDa. Consequently, the shorter arm together
with the hinge would be large enough to account for the 700 kDa
complex that we observed in native gels. Considering that NOT1
was used as bait, it is likely, that the 700 kDa sub-complex con-
tained the NOT1-protein.
The relative arrangement of both arms varied between different
reconstructions indicating ﬂexibility of the whole assembly and
explaining the limited resolution of the map. Both arms form an
accessible cavity in their centre, which could provide an extensive
platform for controlled interaction with RNA and accessory regu-
lating factors.
The current knowledge on binary protein-protein interactions
and the lack of high-resolution structures of individual subunits
and sub-complexes leave ambiguities in the interpretation of the
map of the CCR4-NOT-complex. Considering that NOT1 is the
major scaffolding protein to which the other NOT proteins bind
[4] suggests that the shorter arm is mainly formed by the NOT-
proteins, which account for ca. 500 kDa. Furthermore, NOT1 is in
contact with CAF1, which binds to CCR4 [4]. This could place
CCR4 at the strategic position in the hinge-domain, which has a
similar shape and dimension as the catalytic domain of the human
homologue of CCR4 [17]. It is likely that the remaining CAF40 and
CAF130 account for most of the longer arm, which agrees with the
lack of direct interactions between CAF40 and CAF130 with the
NOT2–5 proteins.
Accession numbers
The map was deposited in the EMDB (ID 1901).
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